A significant regulatory event caused shares of UniQure N.V. (NASDAQ: QURE) to spike up 39.04% to $13.06. The U.S. Food and Drug Administration (FDA) has
UniQure N.V.’s (NASDAQ: QURE) stock is rising sharply this morning after the company announced a significant milestone in its regulatory licensing course. According to the
In recent trading sessions, UniQure (NASDAQ: QURE) shares have soared by 56.15% to $10.41, bolstered by optimistic interim findings from ongoing clinical trials. The data
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.